Patents by Inventor Laura Scandurra

Laura Scandurra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions with antitumour activity
    Patent number: 6673839
    Abstract: Acylcarnitines, such as L-acetylcarnitine (I) were found to have marked antitumour activity, which can be further increased by simultaneous administration of somatosstatin.
    Type: Grant
    Filed: May 10, 2001
    Date of Patent: January 6, 2004
    Assignee: Universita' Degli Studi di Catania
    Inventors: Laura Scandurra, Franca Maria Stivala, Eugenia Allegra, Grazia Rapisarda
  • Use of L-acetylcarnitine for the treatment of AIDS
    Patent number: 5656628
    Abstract: This invention relates to the use of L-acylcarnitine for the preparation of a drug and a technique for relieving the disease symptoms appearing in AIDS by administering an L-acylcarnitine. The invention furthermore relates to a drug for this purpose, characterized in content by L-acylcarnitine as active principle. The preferred L-acylcarnitine is L-acetylcarnitine.
    Type: Grant
    Filed: December 27, 1994
    Date of Patent: August 12, 1997
    Assignee: ZW Biomedical Research AG
    Inventors: Roger Weil, Laura Scandurra
  • Acyl-carnitine for the treatment and prevention of viral infections
    Patent number: 5314689
    Abstract: Acyl-Carnitine in pharmaceutical formulations provides therapeutic and preventive antiviral action against HSV, CMV, VZV, HIV and others.
    Type: Grant
    Filed: March 21, 1990
    Date of Patent: May 24, 1994
    Assignee: Attilio Bernardini
    Inventors: Laura Scandurra, Laure Aurelian